| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Medical Biosciences, Medical Biochemistry (K.L., P.W., T.N.), and Obstetrics and Gynecology (J.O.), Umeå University, S-901 87 Umeå, Sweden
Address all correspondence and requests for reprints to: Professor Tor Ny, Department of Medical Biosciences, Medical Biochemistry, Umeå University, S-901 87 Umeå, Sweden. E-mail: tor.ny{at}medchem.umu.se
The corpus luteum (CL) is a transient endocrine organ that secretes
progesterone to support pregnancy. The CL is formed from an ovulated
follicle in a process that involves extensive angiogenesis and tissue
remodeling. If fertilization does not occur or implantation is
unsuccessful, the CL will undergo regression, which involves extensive
tissue degradation. Extracellular proteases, such as serine proteases
and matrix metalloproteinases (MMPs), are thought to play important
roles in both the formation and regression of the CL. In this study, we
have examined the physiological regulation pattern and cellular
distribution of messenger RNAs coding for gelatinase A (MMP-2),
collagenase-3 (MMP-13), membrane type MMP 1 (MT1-MMP, MMP-14), and the
major MMP inhibitor, tissue inhibitor of MMPs type 1 (TIMP-1) in the CL
of adult pseudopregnant (psp) rat. Northern blot and in
situ hybridization analyses revealed that gelatinase A
messenger RNA was mainly expressed during luteal development,
indicating that gelatinase A may be associated with the
neovascularization and tissue remodeling that takes place during CL
formation. Collagenase-3 had a separate expression pattern and was only
expressed in the regressing CL, suggesting that this MMP may be related
with luteal regression. MT1-MMP that in vitro can
activate progelatinase A and procollagenase-3 was constitutively
expressed during the formation, function, and regression of the CL and
may therefore be involved in the activation of these MMPs. TIMP-1 was
induced during both the formation and regression of the CL, suggesting
that this inhibitor modulates MMP activity during these processes. To
test whether the induction of collagenase-3 and TIMP-1 is coupled with
luteal regression, we prolonged the luteal phase by performing
hysterectomies, and induced premature luteal regression by treating the
pseudopregnant rats with a PGF2
analog, cloprostenol. In
both treatments, collagenase-3 and TIMP-1 were induced only after the
serum level of progesterone had decreased, suggesting that
collagenase-3 and TIMP-1 are induced by physiological signals, which
initiate functional luteolysis to play a role in tissue degradation
during structural luteolysis. In conclusion, our data suggest that
gelatinase A, collagenase-3, and MT1-MMP may have separate functions
during the CL life span: gelatinase A mainly takes part in CL
formation, whereas collagenase-3 mainly takes part in luteal
regression; MT1-MMP is constitutively expressed during the CL life span
and may therefore serve as an in vivo activator of both
gelatinase A and collagenase-3. TIMP-1 is up-regulated both during the
formation and regression of the CL and may therefore regulate MMP
activity during both processes.
This article has been cited by other articles:
![]() |
F. Li and T. E. Curry Jr. Regulation and Function of Tissue Inhibitor of Metalloproteinase (TIMP) 1 and TIMP3 in Periovulatory Rat Granulosa Cells Endocrinology, August 1, 2009; 150(8): 3903 - 3912. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wahlberg, A. Nylander, N. Ahlskog, K. Liu, and T. Ny Expression and Localization of the Serine Proteases High-Temperature Requirement Factor A1, Serine Protease 23, and Serine Protease 35 in the Mouse Ovary Endocrinology, October 1, 2008; 149(10): 5070 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wahlberg, I. Boden, J. Paulsson, L. R. Lund, K. Liu, and T. Ny Functional Corpora Lutea Are Formed in Matrix Metalloproteinase Inhibitor-Treated Plasminogen-Deficient Mice Endocrinology, March 1, 2007; 148(3): 1226 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stocco, C. Telleria, and G. Gibori The Molecular Control of Corpus Luteum Formation, Function, and Regression Endocr. Rev., February 1, 2007; 28(1): 117 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ben-Ami, S. Freimann, L. Armon, A. Dantes, R. Ron-El, and A. Amsterdam Novel function of ovarian growth factors: combined studies by DNA microarray, biochemical and physiological approaches Mol. Hum. Reprod., July 1, 2006; 12(7): 413 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bu, C. Cao, Y. Yang, C. Miao, Z. Hu, Y. Cao, Q. A. Sang, and E. Duan Localization and temporal regulation of tissue inhibitor of metalloproteinases-4 in mouse ovary. Reproduction, June 1, 2006; 131(6): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McDonnel Smedts and T.E. Curry Jr. Expression of Basigin, an Inducer of Matrix Metalloproteinases, in the Rat Ovary Biol Reprod, July 1, 2005; 73(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo and T. E. Curry Jr Regulation of Matrix Metalloproteinase-19 Messenger RNA Expression in the Rat Ovary Biol Reprod, December 1, 2004; 71(6): 1796 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-C. Ke, L.-C. Chuang, M.-T. Lee, Y. J. Chen, S.-W. Lin, P. S. Wang, D. M. Stocco, and J.-J. Hwang The Modulatory Role of Transforming Growth Factor {beta}1 and Androstenedione on Follicle-Stimulating Hormone-Induced Gelatinase Secretion and Steroidogenesis in Rat Granulosa Cells Biol Reprod, May 1, 2004; 70(5): 1292 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo, L. E. Thomas, S. E. Wheeler, and T. E. Curry Jr Membrane Type 1-Matrix Metalloproteinase (MMP)-Associated MMP-2 Activation Increases in the Rat Ovary in Response to an Ovulatory Dose of Human Chorionic Gonadotropin Biol Reprod, April 1, 2004; 70(4): 1024 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liu, Q. Feng, H.-J. Gao, Z.-Y. Hu, R.-J. Zou, Y.-C. Li, and Y.-X. Liu Expression and Regulation of Plasminogen Activators, Plasminogen Activator Inhibitor Type-1, and Steroidogenic Acute Regulatory Protein in the Rhesus Monkey Corpus Luteum Endocrinology, August 1, 2003; 144(8): 3611 - 3617. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Curry Jr and S. E. Wheeler Cellular Localization of Tissue Inhibitors of Metalloproteinases in the Rat Ovary Throughout Pseudopregnancy Biol Reprod, December 1, 2002; 67(6): 1943 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, L. Yan, M. A. Moses, and P. C.W. Tsang Bovine Membrane-Type 1 Matrix Metalloproteinase: Molecular Cloning and Expression in the Corpus Luteum Biol Reprod, July 1, 2002; 67(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Towle, P. C.W. Tsang, R. A. Milvae, M. K. Newbury, and J. A. McCracken Dynamic In Vivo Changes in Tissue Inhibitors of Metalloproteinases 1 and 2, and Matrix Metalloproteinases 2 and 9, During Prostaglandin F2{alpha}-Induced Luteolysis in Sheep Biol Reprod, May 1, 2002; 66(5): 1515 - 1521. [Abstract] [Full Text] |
||||
![]() |
T. Teesalu, A. E. Hinkkanen, and A. Vaheri Coordinated Induction of Extracellular Proteolysis Systems During Experimental Autoimmune Encephalomyelitis in Mice Am. J. Pathol., December 1, 2001; 159(6): 2227 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Simpson, M. J. Byers, and T. E. Curry Jr. Spatiotemporal Messenger Ribonucleic Acid Expression of Ovarian Tissue Inhibitors of Metalloproteinases throughout the Rat Estrous Cycle Endocrinology, May 1, 2001; 142(5): 2058 - 2069. [Abstract] [Full Text] |
||||
![]() |
T. E. Curry Jr and K. G. Osteen Cyclic Changes in the Matrix Metalloproteinase System in the Ovary and Uterus Biol Reprod, May 1, 2001; 64(5): 1285 - 1296. [Abstract] [Full Text] |
||||
![]() |
E. Shalev, S. Goldman, and I. Ben-Shlomo The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women Mol. Hum. Reprod., April 1, 2001; 7(4): 325 - 331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |